机构:[1]Department of Medical Genetics, Yunnan Provincial Key Laboratory for Birth Defects and Genetic Diseases, National Health Commission Key Laboratory of Preconception Health Birth in Western China, the First People’s Hospital of Yunnan Province, Kunming 650100, P.R. China门急诊片医学遗传科云南省第一人民医院[2]Department of Obstetrics and Gynecology, The First People's Hospital of Yunnan Province, Kunming 650100, China外科片产科妇科云南省第一人民医院[3]Institute of Neuroscience, Kunming Medical University, Kunming, 650500, P.R. China[4]Department of Pathology, The First Affiliated Hospital of University of Science and Technology of China, Hefei, 230001, P.R. China[5]Department of Laboratory Medicine, The Third People’s Hospital of Yunnan Province, Kunming 650200, China[6]Medical school, Kunming University of Science and Technology, Kunming 650100, China[7]Department of hematology, Yunnan Provincial Clinical Medical Center for Blood Diseases and Thrombosis Prevention and Treatment, the First People’s Hospital of Yunnan Province, Kunming 650100, China.内科片血液内科云南省第一人民医院
This study was supported by Ten Thousand People Planning Commission of Yunnan
Province (KH-SWR-MY-2020-011), Young and Middle-Aged Academic Leaders Planning
Commission of Yunnan Province (202105AC160034), and Basic Research Project-Key
Projects of Yunnan Province (202301AS070007).
第一作者机构:[1]Department of Medical Genetics, Yunnan Provincial Key Laboratory for Birth Defects and Genetic Diseases, National Health Commission Key Laboratory of Preconception Health Birth in Western China, the First People’s Hospital of Yunnan Province, Kunming 650100, P.R. China[2]Department of Obstetrics and Gynecology, The First People's Hospital of Yunnan Province, Kunming 650100, China
共同第一作者:
通讯作者:
通讯机构:[1]Department of Medical Genetics, Yunnan Provincial Key Laboratory for Birth Defects and Genetic Diseases, National Health Commission Key Laboratory of Preconception Health Birth in Western China, the First People’s Hospital of Yunnan Province, Kunming 650100, P.R. China[6]Medical school, Kunming University of Science and Technology, Kunming 650100, China[7]Department of hematology, Yunnan Provincial Clinical Medical Center for Blood Diseases and Thrombosis Prevention and Treatment, the First People’s Hospital of Yunnan Province, Kunming 650100, China.
推荐引用方式(GB/T 7714):
Zhang Jie,Dong Wei,Yang Qin,et al.Dysregulation of G6PD by HPV E6 exacerbates cervical cancer by activating the STAT3/PLOD2 pathway[J].Carcinogenesis.2025,doi:10.1093/carcin/bgaf005.
APA:
Zhang Jie,Dong Wei,Yang Qin,Liu Li-Na,Cai Xi-Lun...&Zhang Jie.(2025).Dysregulation of G6PD by HPV E6 exacerbates cervical cancer by activating the STAT3/PLOD2 pathway.Carcinogenesis,,
MLA:
Zhang Jie,et al."Dysregulation of G6PD by HPV E6 exacerbates cervical cancer by activating the STAT3/PLOD2 pathway".Carcinogenesis .(2025)